- €1.22bn
- €1.24bn
- €477.58m
- 87
- 19
- 89
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 280 | 236 | 388 | 522 | 478 |
Cost of Revenue | |||||
Gross Profit | 205 | 176 | 263 | 348 | 333 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 239 | 211 | 349 | 457 | 429 |
Operating Profit | 40.9 | 24.9 | 38.3 | 64.5 | 48.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 40.1 | 23.7 | 36 | 59 | 44 |
Provision for Income Taxes | |||||
Net Income After Taxes | 29.3 | 17.6 | 28.2 | 43.8 | 32.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 29.3 | 17.5 | 28.3 | 44.4 | 33.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 29.3 | 17.5 | 28.3 | 44.4 | 33.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.904 | 0.557 | 0.918 | 1.24 | 0.901 |
Dividends per Share |